22nd Century Group Stock Forecast, Price & News

22nd Century Group (NASDAQ:XXII) Frequently Asked Questions

Is 22nd Century Group a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" 22nd Century Group stock.
View analyst ratings for 22nd Century Group or view top-rated stocks.

Are investors shorting 22nd Century Group?

22nd Century Group saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 12,520,000 shares, an increase of 51.0% from the December 15th total of 8,290,000 shares. Based on an average daily volume of 3,480,000 shares, the short-interest ratio is presently 3.6 days.
View 22nd Century Group's Short Interest.

When is 22nd Century Group's next earnings date?

22nd Century Group is scheduled to release its next quarterly earnings announcement on Thursday, March 10th 2022.
View our earnings forecast for 22nd Century Group.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) announced its quarterly earnings data on Thursday, November, 4th. The biotechnology company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.02. The biotechnology company had revenue of $7.81 million for the quarter, compared to analysts' expectations of $8 million. 22nd Century Group had a negative net margin of 82.69% and a negative trailing twelve-month return on equity of 38.09%.
View 22nd Century Group's earnings history.

What price target have analysts set for XXII?

2 brokerages have issued 1 year target prices for 22nd Century Group's stock. Their forecasts range from $5.00 to $8.50. On average, they expect 22nd Century Group's share price to reach $6.75 in the next year. This suggests a possible upside of 173.3% from the stock's current price.
View analysts' price targets for 22nd Century Group or view top-rated stocks among Wall Street analysts.

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the following people:

• James A Mish, Chief Executive Officer
• Michael J. Zercher, President & Chief Operating Officer
• Richard F. Fitzgerald, Chief Financial Officer
• Juan Sanchez Tamburrino, Vice President-Research & Development
• Steven P. Przybyla, Secretary, Vice President & General Counsel

Who are some of 22nd Century Group's key competitors?

Some companies that are related to 22nd Century Group include Innovative Industrial Properties (IIPR), Canopy Growth (WEED), Cronos Group (MJN), CanniMed Therapeutics (CMED), OrganiGram (OGI), GrowGeneration (GRWG), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Bioventix (BVXP), Net Savings Link (NSAV), Maple Leaf Green World (MGW), KushCo (KSHB), Unrivaled Brands (TRTC) and General Cannabis (CANN).
View all of XXII's competitors.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), (CGC), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI).

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the NASDAQ under the ticker symbol "XXII."

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $2.47.

How much money does 22nd Century Group make?

22nd Century Group has a market capitalization of $401.96 million and generates $28.10 million in revenue each year. The biotechnology company earns $-19.71 million in net income (profit) each year or ($0.17) on an earnings per share basis.

How many employees does 22nd Century Group have?

22nd Century Group employs 67 workers across the globe.

What is 22nd Century Group's official website?

The official website for 22nd Century Group is www.xxiicentury.com.

Where are 22nd Century Group's headquarters?

22nd Century Group is headquartered at 9530 Main St, CLARENCE, NY 14031-1915, United States.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at (716) 270-1523, via email at [email protected], or via fax at 716-877-3064.